Zeke Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.99M Buy
5,442
+1,378
+34% +$489K 0.13% 74
2022
Q3
$1.31M Buy
4,064
+1
+0% +$317 0.1% 102
2022
Q2
$1.32M Buy
4,063
+164
+4% +$49.2K 0.09% 106
2022
Q1
$1.12M Buy
+3,899
New +$1M 0.06% 128
2020
Q2
Sell
-1,654
Closed -$229K 245
2020
Q1
$229K Sell
1,654
-10,968
-87% -$1.51M 0.06% 176
2019
Q4
$1.66M Sell
12,622
-663
-5% -$76.9K 0.14% 123
2019
Q3
$1.49M Buy
13,285
+258
+2% +$28.7K 0.13% 131
2019
Q2
$1.44M Sell
13,027
-3,072
-19% -$362K 0.14% 134
2019
Q1
$2.09M Sell
16,099
-10,436
-39% -$1.27M 0.19% 96
2018
Q4
$3.07M Sell
26,535
-14,184
-35% -$1.58M 0.29% 71
2018
Q3
$4.37M Buy
40,719
+300
+0.7% +$30K 0.36% 50
2018
Q2
$3.45M Buy
40,419
+12,853
+47% +$1.06M 0.32% 59
2018
Q1
$2.13M Buy
27,566
+1,905
+7% +$153K 0.2% 90
2017
Q4
$2.17M Buy
25,661
+1,815
+8% +$154K 0.23% 72
2017
Q3
$2.04M Buy
23,846
+14,632
+159% +$1.2M 0.28% 63
2017
Q2
$758K Buy
9,214
+1,828
+25% +$149K 0.15% 92
2017
Q1
$621K Buy
7,386
+2,468
+50% +$198K 0.13% 89
2016
Q4
$362K Buy
+4,918
New +$366K 0.1% 111

Other funds holding LLY

Zeke Capital Advisors's LLY Position: Q4 2022 in Review

Zeke Capital Advisors increased its Eli Lilly (LLY) stake by 34% in Q4 2022, buying an estimated $489K and bringing the position to 5,442 shares worth $1.99M. The position accounts for 0.13% of the portfolio, ranked #74.

Zeke Capital Advisors first reported a position in LLY in Q4 2016 and has held it in 18 quarters since. The position peaked at $4.37M in Q3 2018. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Zeke Capital Advisors held 5,442 shares of Eli Lilly worth $1.99M as of Q4 2022.
  • Zeke Capital Advisors bought 1,378 Eli Lilly shares in Q4 2022, an estimated $489K.
  • Eli Lilly made up 0.13% of Zeke Capital Advisors's portfolio in Q4 2022, its #74 holding.
  • Zeke Capital Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 18 quarters since.
  • Zeke Capital Advisors's Eli Lilly position peaked at $4.37M in Q3 2018.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.